|
IS RECOMBINANT-HUMAN ERYTHROPOIETIN RESISTANCE ANOTHER PREDICTOR OF CARDIOVASCULAR DISEASE IN END-STAGE RENAL FAILURE PATIENTS? Paraskevi Tseke, MD. and George Tsirpanlis, MD.
Greece | ||||
|
(c) Copyright 2003, UniNet. All Rights Reserved.
Version 2.X
|
|